2,366 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Purchased by Cornercap Investment Counsel Inc.

Cornercap Investment Counsel Inc. bought a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) in the fourth quarter, Holdings Channel.com reports. The firm bought 2,366 shares of the company’s stock, valued at approximately $439,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of INSP. Pictet Asset Management Holding SA increased its position in Inspire Medical Systems by 14.2% in the 4th quarter. Pictet Asset Management Holding SA now owns 4,298 shares of the company’s stock valued at $797,000 after acquiring an additional 536 shares during the period. New Age Alpha Advisors LLC acquired a new position in shares of Inspire Medical Systems during the fourth quarter valued at $453,000. Norges Bank bought a new stake in shares of Inspire Medical Systems during the fourth quarter valued at about $10,681,000. WINTON GROUP Ltd grew its position in Inspire Medical Systems by 15.6% in the 4th quarter. WINTON GROUP Ltd now owns 5,977 shares of the company’s stock valued at $1,108,000 after buying an additional 806 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in Inspire Medical Systems by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 3,270,357 shares of the company’s stock valued at $606,259,000 after buying an additional 38,219 shares during the period. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Price Performance

Shares of NYSE:INSP opened at $156.91 on Friday. The stock has a market capitalization of $4.67 billion, a P/E ratio of 90.70, a P/E/G ratio of 2.86 and a beta of 1.48. The business has a 50-day moving average of $179.14 and a two-hundred day moving average of $190.04. Inspire Medical Systems, Inc. has a fifty-two week low of $123.00 and a fifty-two week high of $257.40.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. As a group, research analysts expect that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Analysts Set New Price Targets

INSP has been the topic of a number of research reports. Stifel Nicolaus dropped their price objective on Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating on the stock in a research note on Tuesday, January 21st. Morgan Stanley reduced their target price on Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating for the company in a report on Tuesday, February 11th. KeyCorp reissued an “overweight” rating and set a $234.00 price target (down from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Piper Sandler dropped their target price on Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating on the stock in a report on Monday, February 10th. Finally, Wells Fargo & Company lowered their price objective on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 11th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $226.70.

Insider Buying and Selling

In other news, CTO John Rondoni sold 583 shares of the business’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the transaction, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.76. The trade was a 5.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Randy Ban sold 25,584 shares of Inspire Medical Systems stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $183.50, for a total value of $4,694,664.00. Following the sale, the insider now directly owns 7,259 shares in the company, valued at approximately $1,332,026.50. This trade represents a 77.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 26,225 shares of company stock valued at $4,806,530. Company insiders own 4.10% of the company’s stock.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.